Study Summary
The purpose of this study is to evaluate the safety and efficiency of CD123-Targeted CAR-T in Treating Patients with relapsed/refractory AML
Want to learn more about this trial?
Request More InfoInterventions
CART-123 cellsBIOLOGICAL
CD123-Targeted CAR-T cells are infused to patient received FC chemotherapy
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| 307 Hospital of PLA | Beijing | Beijing 100071 | China |